Stents Drug Eluting

Biotronik, ORIENT trial results, EuroPCR 2016, Orsiro DES, hybrid drug-eluting stent
News | Stents Drug Eluting | June 03, 2016
June 3, 2016 — Biotronik announced results establishing non-inferiority of the Orsiro hybrid...

Biosensors' Biomatrix stent.

Feature | Stents | May 16, 2016
May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables...
Medtronic, Drug-Filled Stent, RevElution Trial results, ACC.16, CE Mark
News | Stents Drug Eluting | April 21, 2016
April 21, 2016 — Medtronic plc announced new clinical data from one of the endpoints in the RevElution Trial for its...
Absorb, bioresorbable stents
Feature | Stents Bioresorbable | April 13, 2016 | Dave Fornell
Bioresorbable stents have been one of the hottest new cardiovascular technologies discussed at cardiology meetings over...
Biotronik, BIOSCIENCE trial, Orsiro hybrid DES, drug-eluting stent, STEMI heart attack patients
News | Stents Drug Eluting | March 07, 2016
March 7, 2016 — Biotronik announced publication of results from the...
Medtronic, CE Mark, Resolute Onyx DES, drug-eluting stent, expanded sizes and indications
News | Stents Drug Eluting | February 02, 2016
February 2, 2016 — Medtronic plc announced the recent CE Mark and commercial launch for an expanded size matrix of the...
News | Stents Drug Eluting | January 08, 2016
January 8, 2016 — In December, Stentys announced completion of patient enrollment in DESSOLVE III. The 1,400-patient...
Blog | Cath Lab | November 05, 2015
For the past few years, the focus of the annual Transcatheter Cardiovascular Therapeutics (TCT) meetings has been on...
Videos | TCT | November 05, 2015
DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies...
Videos | TCT | November 05, 2015
Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015...
News | Stents Bioresorbable | October 30, 2015
October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable...
Videos | Stents Drug Eluting | October 30, 2015
Dr. Stephen Worthley, Ph.D., director of the cardiac cath labs at Royal Adelaide Hospital at the University of Adelaide...
Videos | Stents Bioresorbable | October 30, 2015
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for...
News | Stents Drug Eluting | October 27, 2015
October 27, 2015 — Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA...
REMEDEE Registry, one-year outcomes, Combo dual therapy stent, OrbusNeich, TCT 2015
News | Stents Drug Eluting | October 26, 2015
October 26, 2015 — OrbusNeich announced the presentation of the one-year clinical outcomes from the 1,000-patient...
Overlay Init